IL281663A - Therapeutic uses of atomic quantum clusters - Google Patents

Therapeutic uses of atomic quantum clusters

Info

Publication number
IL281663A
IL281663A IL281663A IL28166321A IL281663A IL 281663 A IL281663 A IL 281663A IL 281663 A IL281663 A IL 281663A IL 28166321 A IL28166321 A IL 28166321A IL 281663 A IL281663 A IL 281663A
Authority
IL
Israel
Prior art keywords
therapeutic uses
atomic quantum
quantum clusters
clusters
atomic
Prior art date
Application number
IL281663A
Other languages
English (en)
Hebrew (he)
Original Assignee
Nanogap Sub Nm Powder S A
Univ Santiago Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanogap Sub Nm Powder S A, Univ Santiago Compostela filed Critical Nanogap Sub Nm Powder S A
Publication of IL281663A publication Critical patent/IL281663A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/06—Alloys based on silver
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
    • C25C1/00—Electrolytic production, recovery or refining of metals by electrolysis of solutions
    • C25C1/12—Electrolytic production, recovery or refining of metals by electrolysis of solutions of copper
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
    • C25C1/00—Electrolytic production, recovery or refining of metals by electrolysis of solutions
    • C25C1/20—Electrolytic production, recovery or refining of metals by electrolysis of solutions of noble metals
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
    • C25C5/00—Electrolytic production, recovery or refining of metal powders or porous metal masses
    • C25C5/02—Electrolytic production, recovery or refining of metal powders or porous metal masses from solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F2202/00—Treatment under specific physical conditions
    • B22F2202/11—Use of irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Nanotechnology (AREA)
  • Electrochemistry (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL281663A 2018-09-26 2021-03-21 Therapeutic uses of atomic quantum clusters IL281663A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18196959 2018-09-26
EP18196963 2018-09-26
PCT/ES2019/070637 WO2020065115A2 (es) 2018-09-26 2019-09-25 Usos terapéuticos de clústeres cuánticos atómicos

Publications (1)

Publication Number Publication Date
IL281663A true IL281663A (en) 2021-05-31

Family

ID=68342935

Family Applications (1)

Application Number Title Priority Date Filing Date
IL281663A IL281663A (en) 2018-09-26 2021-03-21 Therapeutic uses of atomic quantum clusters

Country Status (11)

Country Link
US (1) US20220031740A1 (https=)
EP (1) EP3862109A2 (https=)
JP (2) JP2022502450A (https=)
KR (1) KR20210086606A (https=)
CN (2) CN113179632A (https=)
AU (2) AU2019349780B2 (https=)
BR (1) BR112021005775A2 (https=)
CA (1) CA3111915A1 (https=)
IL (1) IL281663A (https=)
MX (1) MX2021003566A (https=)
WO (1) WO2020065115A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1303421C (zh) * 2004-03-24 2007-03-07 南京大学 一种用于有机氯、有机磷农药分析的同步净化提取方法
KR102927722B1 (ko) * 2020-05-09 2026-02-19 선전 프로파운드 뷰 파마슈티칼 테크놀로지 컴퍼니 리미티드 비정형 항정신병약물에 의해 유발되는 부작용의 치료
CN111906328B (zh) * 2020-08-11 2022-10-25 苏州大学 一种177Lu标记的金纳米团簇及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2277531B2 (es) * 2005-08-03 2008-07-16 Universidad De Santiago De Compostela Procedimiento para la obtencion de clusteres cuanticos atomicos.
CN101113046A (zh) * 2006-07-25 2008-01-30 安正五 纳米胶体银水的制备方法
ES2319064B1 (es) * 2007-10-05 2010-02-15 Universidad De Santiago De Compostela Uso de clusteres cuanticos atomicos (aqcs) como antimicrobianos y biocidas.
CN101486733B (zh) * 2009-03-09 2011-05-25 华南师范大学 含氧桥双核钼原子簇化合物及其制备方法和用途
EP2457572A1 (en) * 2010-11-05 2012-05-30 Universidade De Santiago De Compostela Use of atomic quantum clusters (aqcs) in the prevention of cell proliferative disorders, viral infections and autoimmune diseases
WO2015015301A2 (en) * 2013-07-31 2015-02-05 Palama Ilaria El Cancer therapy with silver nanoparticles
KR20210021306A (ko) * 2018-06-12 2021-02-25 나노갭 서브-엔엠-파우더, 쏘시에다드 아노니마 정제된 원자 양자 클러스터를 제조하는 방법

Also Published As

Publication number Publication date
MX2021003566A (es) 2021-08-16
AU2025238114A1 (en) 2025-10-23
WO2020065115A2 (es) 2020-04-02
BR112021005775A2 (pt) 2021-06-29
EP3862109A2 (en) 2021-08-11
CN113179632A (zh) 2021-07-27
AU2019349780A1 (en) 2021-03-25
WO2020065115A3 (es) 2020-05-22
US20220031740A1 (en) 2022-02-03
AU2019349780B2 (en) 2025-07-03
CA3111915A1 (en) 2020-04-02
JP2022502450A (ja) 2022-01-11
JP2024122998A (ja) 2024-09-10
CN120053481A (zh) 2025-05-30
KR20210086606A (ko) 2021-07-08

Similar Documents

Publication Publication Date Title
IL244111A0 (en) Survival benefit in patients with solid tumors with elevated c-reactive protein levels
LT4331584T (lt) Lanifibranoro deuterintų darinių terapietiniai naudojimai
FR3028909B3 (fr) Structure amelioree d'actionneur lineaire
EP3735463A4 (en) Cytotoxicity-inducing therapeutic agent
PL3570854T3 (pl) Zastosowanie terapeutyczne proszku z owadów
IL282330A (en) Therapeutic compounds
IL251136A0 (en) Combination therapy of inhibitors of c-c chemokine receptor type 9 (ccr9) and anti-alha4beta7 integrin blocking antibodies
EP3347334A4 (en) DEHYDROHALOGENICATION OF FLUOROCHOLE HYDROGEN
SI3565592T1 (sl) Zdravljenje presnovnih bolezni z zaviranjem aktivacije miostatina
EP3506254A4 (en) SOUNDPROOF STRUCTURE
IL281663A (en) Therapeutic uses of atomic quantum clusters
PL3390450T3 (pl) Humanizowane przeciwciało anty-cd28 formułowane do podawania ludziom
HUE045409T2 (hu) Új PI3K gamma inhibitor peptid légzõszervi betegségek kezelésére
EP3305523A4 (en) LAYER BODY
EP3688772A4 (en) QUANTUM TOMOGRAPHY FACILITATION
KR20180084928A (ko) 특히 전류의 도움으로 인간 케라틴 물질을 처리하기 위한 디바이스
IL289338A (en) Therapeutic interactions of leucomethylthioninium
IL280101A (en) Peptide compounds and therapeutic uses of same
EP3727126A4 (en) MULTI-PURPOSE SCOPE
DK3597169T3 (da) Sauna
JP1635114S (ja) 椅子
UA38301S (uk) Стілець
ITUA20163954A1 (it) "integrazione dell'ordine logico"
DK3576795T3 (da) Oralt skjoldbruskkirtelterapeutikum
PL3609860T3 (pl) Sposoby wytwarzania fenoksyetanolu